top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


The Enormous Impact of EVA/PCD Chemosensitivity Testing in Patients with Rare Cancers: Durable Benefit Provided by An Unexpected Recommendation
The drug we recommended, Pazopanib, would not normally be expected to have activity in this rare and aggressive cancer.

Dr. Robert A. Nagourney, MD
Nov 32 min read


The Art of Medicine
Her findings revealed a biopsy proven breast cancer, a nodule in the lung and a large mass in the right kidney.

Dr. Robert A. Nagourney, MD
Oct 52 min read


For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Dr. Robert A. Nagourney, MD
Jan 23, 20243 min read


Recurrent Lung Cancer Patients Need To “Get Down On It”
George Brown is alive today because our laboratory analysis identified a simple 2 drug combination that now one else thought to give him.

Dr. Robert A. Nagourney, MD
Oct 25, 20233 min read
bottom of page
